Skip to main content

Table 3 – Treatment modality prescribed in studied population

From: Etiology of chronic urticaria: the Ecuadorian experience

Treatment

Overall patients (n = 112) n (%)

Sg H1-antihisatmine alone

50 (44.6)

Sg H1-antihisatmine + another drug

47 (42.0)

Fg H1-antihistamine + Sg H1-antihisatmine

12 (10.7)

Fg H1-antihisatmine

3 (2.7)

  1. All data are presented as frequencies and percentages. The chi-square goodness-of-fit test indicated that the proportions of treatment modalities prescribed in the study were statistically significant (p = 0.00). Fg H1-antihistamine, first-generation H1 antihistamine; Sg H1-antihisatmine, second-generation H1 antihistamine
Back to article page

World Allergy Organization Journal

ISSN: 1939-4551

Contact us